资讯

If you spend most of your day slouched over a desk, then hi, same! I do my best to get up and move around every hour, but to ...
Nectero Medical, a clinical-stage biotechnology company developing therapies for aneurysmal disease, announced today that the American Medical Association’s CPT Editorial Panel has approved two ...
This newly granted PLA code assigns a unique identifier to the test, allowing for the submission of claims to Medicare and private insurers for the Company’s inFoods IBS test once the code becomes ...
Milestone paves the way for future reimbursement of the Nectero EAST® System TEMPE, Az., June 12, 2025 (GLOBE NEWSWIRE) -- Nectero Medical, a clinical-stage biotechnology company developing therapies ...
Novadip is developing NVD003, an autologous therapy derived from adipose stem cells, as a potential single treatment to save limbs and restore mobility in patients with CPTThe RMAT designation is part ...
The acquisition brings together two AI leaders to create the first truly AI-integrated rehab therapy operations ...
Nectero Medical Secures Category III CPT Codes for Investigational Therapy to Treat Small- to Medium-Sized AAAs Milestone paves the way for future reimbursement of the Nectero EAST® System ...
I was preparing for a meeting when my laptop’s touchpad failed me in spectacular fashion. I tried to remain calm. I tried ...
Proton therapy is a type of external beam radiation therapy that delivers high dose radiation directly to cancer cells. Learn about its benefits and uses for breast cancer treatment.